Shares of Gap (GPS) were slightly higher Monday as Piper Jaffray upgraded its rating on the shares to neutral from underweight. Analysts at Piper Jaffray adjusted the rating, as they see accelerating momentum in holiday spending trends, and believe Gap could benefit from this. But they remain concerned about market-share loss at the core Gap division. Analysts maintained their $23 price target.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.